Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2017 (2017), Article ID 5217687, 6 pages
https://doi.org/10.1155/2017/5217687
Research Article

Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients with Psoriasis: An Observational and Epidemiological Study

KTH, Peshawar, Pakistan

Correspondence should be addressed to Abidullah Khan; moc.oohay@kdiba.rd

Received 19 January 2017; Revised 2 March 2017; Accepted 7 March 2017; Published 22 March 2017

Academic Editor: Han J. Moshage

Copyright © 2017 Abidullah Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Griffiths and J. N. Barker, “Pathogenesis and clinical features of psoriasis,” The Lancet, vol. 370, no. 9583, pp. 263–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. K. Kurd and J. M. Gelfand, “The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004,” Journal of the American Academy of Dermatology, vol. 60, no. 2, pp. 218–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Gelfand, A. L. Neimann, D. B. Shin, X. Wang, D. J. Margolis, and A. B. Troxel, “Risk of myocardial infarction in patients with psoriasis,” Journal of the American Medical Association, vol. 296, no. 14, pp. 1735–1741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Abuabara, R. S. Azfar, D. B. Shin, A. L. Neimann, A. B. Troxel, and J. M. Gelfand, “Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.,” British Journal of Dermatology, vol. 163, no. 3, pp. 586–592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Azfar, N. M. Seminara, D. B. Shin, A. B. Troxel, D. J. Margolis, and J. M. Gelfand, “Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis,” Archives of Dermatology, vol. 148, no. 9, pp. 995–1000, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Langan, N. M. Seminara, D. B. Shin et al., “Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom,” Journal of Investigative Dermatology, vol. 132, no. 3, pp. 556–562, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. N. P. Singh, A. Prakash, S. Kubba et al., “Psoriatic nephropathy—does an entity exist?” Renal Failure, vol. 27, no. 1, pp. 123–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-W. Yang, J. J. Keller, and H.-C. Lin, “Medical comorbidity associated with psoriasis in adults: a population-based study,” British Journal of Dermatology, vol. 165, no. 5, pp. 1037–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Dervisoglu, A. S. Akturk, K. Yildiz, R. Kiran, and A. Yilmaz, “The spectrum of renal abnormalities in patients with psoriasis,” International Urology and Nephrology, vol. 44, no. 2, pp. 509–514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Szepietowski, E. Bielicka, F. Wasik, W. Kopec, and T. Szepietowski, “Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 14, no. 6, pp. 513–514, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Cecchi, G. Seghieri, A. Gironi, F. Tuci, and A. Giomi, “Relation between urinary albumin excretion and skin involvement in patients with psoriasis,” Dermatology, vol. 185, no. 2, pp. 93–95, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Madeddu, P. Ena, N. Glorioso, D. Cerimele, and A. Rappelli, “High prevalence of microproteinuria, an early index of renal impairment, in patients with diffuse psoriasis,” Nephron, vol. 48, no. 3, pp. 222–225, 1988. View at Google Scholar · View at Scopus
  13. D. J. Pearce, A. E. Morrison, K. B. Higgins et al., “The comorbid state of psoriasis patients in a university dermatology practice,” Journal of Dermatological Treatment, vol. 16, no. 5-6, pp. 319–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Kaftan, B. Kaftan, M. F. Toppare, and M. Eksioglu, “Renal involvement in psoriasis,” Dermatology, vol. 192, no. 2, pp. 189–190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Cassano, M. Vestita, M. Panaro, M. Carbonara, and G. A. Vena, “Renal function in psoriasis patients,” European Journal of Dermatology, vol. 21, no. 2, pp. 264–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Imai, T. Kodama, T. Ishino et al., “IgA nephropathy associated with hyper IgAnemia, psoriasis or pustulosis and ossification,” Clinical Nephrology, vol. 44, no. 1, pp. 64–68, 1995. View at Google Scholar · View at Scopus
  17. J. Zadrazil, B. Tichy, P. Horak et al., “IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’,” Journal of Nephrology, vol. 19, no. 3, pp. 382–386, 2006. View at Google Scholar · View at Scopus
  18. T. S. Ahuja, M. Funtanilla, J. J. de Groot, A. Velasco, J. Badalamenti, and S. Wilson, “IgA nephropathy in psoriasis,” American Journal of Nephrology, vol. 18, no. 5, pp. 425–429, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Kaji, Y. Tsukada, A. Shimada et al., “Membranous nephropathy associated with psoriasis vulgaris,” Clinical Nephrology, vol. 42, no. 1, pp. 63–64, 1994. View at Google Scholar · View at Scopus
  20. M. Kim, Y. Ko, U. C. Yeo, Y. Kim, and H. Oh, “Psoriasis and glomerulonephritis,” Clinical and Experimental Dermatology, vol. 23, no. 6, pp. 295–296, 1998. View at Publisher · View at Google Scholar
  21. I. N. Bruce, C. T. Schentag, and D. D. Gladma, “Hyperuricemia in psoriatic arthritis: prevalence and associated features,” Journal of Clinical Rheumatology, vol. 6, no. 1, pp. 6–9, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. K. O'Brown, E. L. Van Nostrand, J. P. Higgins, and S. K. Kim, “The inflammatory transcription factors NFκB, STAT1 and STAT3 drive age-associated transcriptional changes in the human kidney,” PLoS Genetics, vol. 11, no. 12, Article ID e1005734, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Bolignano, F. Mattace-Raso, E. J. G. Sijbrands, and C. Zoccali, “The aging kidney revisited: a systematic review,” Ageing Research Reviews, vol. 14, no. 1, pp. 65–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wan, S. Wang, K. Haynes, M. R. Denburg, D. B. Shin, and J. M. Gelfand, “Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study,” The British Medical Journal, vol. 347, Article ID f5961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Corden, E. Higgins, and C. Smith, “Hypercalcaemia-induced kidney injury caused by the vitamin D analogue calcitriol for psoriasis: a note of caution when prescribing topical treatment,” Clinical and Experimental Dermatology, vol. 41, no. 8, pp. 899–901, 2016. View at Publisher · View at Google Scholar
  26. P. Gisondi and G. Girolomoni, “Glomerular filtration rate in patients with psoriasis treated with etanercept,” Journal of International Medical Research, vol. 44, no. 2, supplement, pp. 106–108, 2016. View at Publisher · View at Google Scholar